Antibiotics that disrupt essential bacterial metabolic pathways are acting as antimetabolites . These chemicals are structurally similar to natural metabolites but just different enough to interfere with normal cell function.
For example, trimethoprim inhibits the synthesis of folic acid, a vitamin which bacteria, unlike humans, must make themselves. Trimethoprim is a structural analogue of dihydrofolic acid, an intermediate compound in the folic acid pathway. Trimethoprim out-competes dihydrofolic acid to react with a specific bacterial enzyme in the pathway, thereby interrupting folic acid synthesis and inhibiting bacterial growth (Figure 7).
The action of trimethoprim illustrated in Figure 7b exemplifies the specific interaction between antibiotic and bacterial target at a molecular level which disrupts a particular cellular process. You will return to this topic in Week 3 in relation to the development of antibiotic resistance.
In the next section, you will look in detail at the mechanism of ß-lactam antibiotics.
OpenLearn - Understanding antibiotic resistance
Except for third party materials and otherwise, this content is made available under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 Licence, full copyright detail can be found in the acknowledgements section. Please see full copyright statement for details.